Abiopharma

ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) Reports the reporting period Financial Results ARCTURUS THERAPEUTICS HOLDINGS INC. (ARCT) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 2061
• Net Income: Not disclosed
• EPS: Not disclosed
• Cash and equivalents: 211375
  • anticipated by the forward-looking statements, including those discussed under the heading "Risk Factors" in Arcturus’ most recent Annual Report on Form 10-K, and in subsequent filings with, or submissions to, the SEC, which are available on the SEC’s website at www.sec.gov. Except as otherwise required by law, Arcturus disclaims any intention or obligation to update or revise any forward-looking statements, which speak only as of the date they were made, whether as a result of new information, future events or circumstances or otherwise. ARCTURUS THERAPEUTICS HOLDINGS INC. AND ITS SUBSIDIARIES CONDENSED CONSOLIDATED BALANCE SHEETS March 31, 2026